Clinical Trials on Posterior Capsule Opacification in India

Total 12 results

Iladevi Cataract and IOL Research Center

Completed

Posterior Capsule Opacification (PCO) With Single Piece Hydrophobic Versus Hydrophillic Intraocular Lens (IOL)

Posterior Capsule Opacification

India
Iladevi Cataract and IOL Research Center

Completed

Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL

Posterior Capsule Opacification

India
Iladevi Cataract and IOL Research Center

Completed

Long-term Evaluation of Single-piece ACrysof IOL Implantation on Development of Posterior Capsule Opacification

Posterior Capsule Opacification After Phacoemulsification and IOL Implantation

India
Aurolab

Completed

Posterior Capsule Opacification Study

Cataract

India
EyePoint Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

Panuveitis | Posterior Uveitis | Intermediate Uveitis

India
Allergan

Completed

A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Posterior Uveitis | Intermediate Uveitis

France, United Kingdom, United States, Spain, Poland, India, South Africa, Korea, Republic of, Canada, Czech Republic, Australia, Germany, Israel, Switzerland, Portugal, Austria, Brazil, Greece
Santen Inc.

Completed

A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program (SPRING)

Non-Infectious Uveitis of the Posterior Segment of the Eye

United States, France, Turkey, Italy, Austria, India
Santen Inc.

Completed

Study Assessing Double-masked Uveitis Treatment (SAKURA)

Uveitis; Posterior, Disorder

United States, France, Italy, Poland, United Kingdom, Germany, Spain, Austria, Colombia, Israel, India, Turkey, Japan, Peru, Argentina, Brazil, Chile
Clearside Biomedical, Inc.

Completed

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

Uveitis, Anterior | Panuveitis | Uveitis | Uveitis, Posterior | Uveitis, Intermediate

United States, India
Lux Biosciences, Inc.

Completed

A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis (LUMINATE)

Panuveitis | Uveitis, Posterior | Uveitis, Intermediate

United States, United Kingdom, Canada, Germany, Austria, France, India
Lux Biosciences, Inc.

Completed

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis (LUMINATE)

Panuveitis | Uveitis, Posterior | Uveitis, Intermediate

United States, United Kingdom, Canada, Germany, Austria, France, India
Clearside Biomedical, Inc.

Completed

Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis (PEACHTREE)

Uveitis, Anterior | Panuveitis | Uveitis | Uveitis, Posterior | Uveitis, Intermediate

United States, Israel, India

Clinical Trials on Posterior Capsule Opacification in India

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations